Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading? Dixitha AnugulaRhanderson CardosoMiguel Cainzos-Achirica Coronary Heart Disease (S. Virani and M. Al Rifai, Section Editors) 30 August 2022 Pages: 755 - 766
Recent Updates in Hypertriglyceridemia Management for Cardiovascular Disease Prevention Renato QuispeTy SweeneyErin D. Michos Coronary Heart Disease (S. Virani and M. Al Rifai, Section Editors) 27 July 2022 Pages: 767 - 778
PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid–Based Therapy Era Ioanna Gouni-BertholdJonas SchwarzHeiner K. Berthold Nonstatin Drugs (L. Tokgozoglu and A.L. Catapano, Section Editors) Open access 28 July 2022 Pages: 779 - 790
Bempedoic Acid: for Whom and When Massimiliano RuscicaCesare R. SirtoriAlberto Corsini Nonstatin Drugs (L. Tokgozoglu and A.L. Catapano, Section Editors) Open access 28 July 2022 Pages: 791 - 801
Inclisiran: How Widely and When Should We Use It? Angela PirilloAlberico Luigi Catapano Nonstatin Drugs (L. Tokgozoglu and A.L. Catapano, Section Editors) Open access 25 July 2022 Pages: 803 - 811
Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women Shreya PatelManish KumarFawaz Alenezi Women and Ischemic Heart Disease (J.M. Peña and F. Lin, Section Editors) 21 July 2022 Pages: 813 - 820
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond Nabil G. SeidahDamien Garçon Genetics and Genomics (R.A. Hegele and L. Brunham, Section Editors) 29 July 2022 Pages: 821 - 830